A detailed characterization of the adult mouse model of glycogen storage disease Ia

被引:14
|
作者
Salganik, Susan V. [1 ,2 ]
Weinstein, David A. [3 ]
Shupe, Thomas D. [1 ,2 ]
Salganik, Max [4 ]
Pintilie, Dana G. [1 ,2 ]
Petersen, Bryon E. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Pediat, Div Pediat Endocrinol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
关键词
Glucose-6-phosphatase; GSD1a mouse model; glycogen storage disease; hypoglycemia; metabolic disorder; MEDIATED GENE-THERAPY; MURINE GLUCOSE-6-PHOSPHATASE; 1A; HYPOGLYCEMIA; MUTATIONS; ADENOMAS; TYPE-1A; CANINE; LIVER; MICE;
D O I
10.1038/labinvest.2009.64
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glycogen storage disease type Ia (GSDIa) is caused by a genetic defect in the hepatic enzyme glucose-6-phosphatase (G6Pase-alpha), which manifests as life-threatening hypoglycemia with related metabolic complications. A G6Pase-alpha knockout (KO) mouse model was generated to study potential therapies for correcting this disorder. Since then, gene therapy studies have produced promising results, showing long-term improvement in liver histology and glycogen metabolism. Under existing protocols, however, untreated KO pups seldom survived weaning. Here, we present a thorough characterization of the G6Pase-alpha KO mouse, as well as the husbandry protocol for rearing this strain to adulthood. These mice were raised with only palliative care, and characterized from birth through 6 months of age. Once KO mice have survived the very frail weaning period, their size, agility, serum lipids and glycemic control improve dramatically, reaching levels approaching their wild-type littermates. In addition, our data reveal that adult mice lacking G6Pase-alpha are able to mate and produce viable offspring. However, liver histology and glycogen accumulation do not improve with age. Overall, the reliable production of mature KO mice could provide a critical tool for advancing the GSDIa field, as the availability of a robust enzyme-deficient adult offers a new spectrum of treatment avenues that would not be tolerated by the frail pups. Most importantly, our detailed characterization of the adult KO mouse provides a crucial baseline for accurately gauging the efficacy of experimental therapies in this important model. Laboratory Investigation (2009) 89, 1032-1042; doi:10.1038/labinvest.2009.64; published online 6 July 2009
引用
收藏
页码:1032 / 1042
页数:11
相关论文
共 50 条
  • [1] Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia)
    Kishnani, PS
    Faulkner, E
    VanCamp, S
    Jackson, M
    Brown, T
    Boney, A
    Koeberl, D
    Chen, YT
    VETERINARY PATHOLOGY, 2001, 38 (01) : 83 - 91
  • [2] Pregnancy in Women With Glycogen Storage Disease Ia and Ib
    Ferrecchia, Iris A.
    Guenette, Ginny
    Potocik, Elizabeth A.
    Weinstein, David A.
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2014, 28 (01) : 26 - 31
  • [3] Activation of glycolysis and apoptosis in glycogen storage disease type Ia
    Sun, Baodong
    Li, Songtao
    Yang, Liu
    Damodaran, Tirupapuliyur
    Desai, Dev
    Diehl, Anna Mae
    Alzate, Oscar
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (04) : 267 - 271
  • [4] Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia
    Yavarow, Zollie A.
    Kang, Hye-Ri
    Waskowicz, Lauren R.
    Bay, Boon-Huat
    Young, Sarah P.
    Yen, Paul M.
    Koeberl, Dwight D.
    HUMAN MOLECULAR GENETICS, 2020, 29 (02) : 286 - 294
  • [5] Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia
    Kanamori, Hiroyuki
    Nakade, Yukiomi
    Yamamoto, Takaya
    Kobayashi, Yuji
    Sato, Ken
    Ito, Kiyoaki
    Ohashi, Tomohiko
    Nakao, Noiku
    Ishii, Norimitsu
    Takahashi, Emiko
    Yokoi, Toyoharu
    Nakao, Haruhisa
    Kurokawa, Tsuyoshi
    Yamaguchi, Chikara
    Yoneda, Masashi
    HEPATOLOGY RESEARCH, 2015, 45 (04) : 494 - 499
  • [6] Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control
    Dambska, M.
    Labrador, E. B.
    Kuo, C. L.
    Weinstein, D. A.
    PEDIATRIC DIABETES, 2017, 18 (05) : 327 - 331
  • [7] Diabetes mellitus in a patient with glycogen storage disease type Ia: A case report
    Cohn A.
    Ohri A.
    Journal of Medical Case Reports, 11 (1)
  • [8] A Mouse Model of Glycogen Storage Disease Type IX-Beta: A Role for Phkb in Glycogenolysis
    Arends, Charles J.
    Wilson, Lane H.
    Estrella, Ana
    Kwon, Oh Sung
    Weinstein, David A.
    Lee, Young Mok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [9] Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-Ia
    Arnaoutova, Irina
    Aratyn-Schaus, Yvonne
    Zhang, Lisa
    Packer, Michael S.
    Chen, Hung-Dar
    Lee, Cheol
    Gautam, Sudeep
    Gregoire, Francine M.
    Leboeuf, Dominique
    Boule, Steven
    Fernandez, Thomas P.
    Huang, Victoria
    Cheng, Lo-, I
    Lung, Genesis
    Bannister, Brianna
    Decker, Jeremy
    Leete, Thomas
    Shuang, Lan S.
    Bock, Caroline
    Kothiyal, Prachi
    Grayson, Phil
    Mok, Ka W.
    Quinn, Jeffrey J.
    Young, Lauren
    Barrera, Luis
    Ciaramella, Giuseppe
    Mansfield, Brian C.
    Chou, Janice Y.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [10] Hepatocellular adenoma in type Ia glycogen storage disease
    Masatoshi Kudo
    Journal of Gastroenterology, 2001, 36 : 65 - 66